SLSSELLAS Life Sciences Group, Inc.

$11.66+615% 1Y

The financials

SELLAS Life Sciences Group, Inc. by the numbers

The next results filing is expected around Nov 11, 2026, the same week as a year ago.

SELLAS Life Sciences Group, Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Operating income−$11M−$6.9Mn/a
Net income−$9.6M−$6.6Mn/a
Diluted EPS−$0.05−$0.07n/a
On our screens:Most shorted stocks